BA
The Boeing Company
BA's outlook is improving, though it still trails on the overall score.
HLIO
Helios Technologies, Inc.
HLIO has the edge over BA overall, supported by stronger valuation and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
HLIO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
HLIO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over HLIO in the historical PE scenario, which offers more potential upside but is not a forecast.
HLIO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $47.69 | — |
| Current | 20x | $47.69 | — |
| Cheap | 21x | $50.21 | +5.3% |
| Fair | 37x | $88.21 | +85% |
| Expensive | 53x | $126 | +163% |
Historical ranges are pointers, not guarantees.
HLIO's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
HLIO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HLIO, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
HLIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.30 | +40% |
| Q3 2026 | $2.36 | +134% |
| Q2 2026 | $2.14 | +106% |
| Q1 2026 | $1.82 | +64% |
| Q4 2025 | $1.45 | +24% |
| Q3 2025 | $1.01 | -11% |
| Q2 2025 | $1.04 | +16% |
| Q1 2025 | $1.11 | +11% |
| Q4 2024 | $1.17 | +2.6% |
HLIO has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over HLIO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
HLIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $229.7M | +4.3% |
| Q2 2026 | $231.9M | +9.1% |
| Q1 2026 | $228.4M | +17% |
| Q4 2025 | $210.8M | +17% |
| Q3 2025 | $220.3M | +13% |
| Q2 2025 | $212.5M | -3.4% |
| Q1 2025 | $195.5M | -7.8% |
| Q4 2024 | $179.5M | -7.2% |
HLIO's revenue has grown year over year for five quarters in a row: $230M last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +12 points |
| Q2 2026 | 14% | +3.7 points |
| Q1 2026 | 13% | +4.4 points |
| Q4 2025 | 12% | +4.8 points |
| Q3 2025 | 0.6% | -11 points |
| Q2 2025 | 10% | -1.5 points |
| Q1 2025 | 8.7% | -0.9 points |
| Q4 2024 | 7.4% | +1.3 points |
HLIO has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over HLIO on cash flow, with more consistent year-over-year improvement.
HLIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.4M | +74% |
| Q2 2026 | $30.6M | -3.2% |
| Q1 2026 | $17.2M | +33% |
| Q4 2025 | $40.5M | +43% |
| Q3 2025 | $18.6M | -35% |
| Q2 2025 | $31.6M | +22% |
| Q1 2025 | $12.9M | +4.9% |
| Q4 2024 | $28.3M | +14% |
HLIO's free cash flow has been positive every quarter for seven years: $121M over the past year, up 32% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HLIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -200K shares |
| 1 year | -0.9% | -300K shares |
| 3 years | -0.3% | -100K shares |
| 5 years | +1.9% | +615K shares |
| Available history | +3.1% | +985K shares |
HLIO has the edge over BA on shareholder dilution, with a more favorable share count trend.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
HLIO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.8x | Healthy |
| Q4 2024 | 1.8x | Healthy |
HLIO has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
HLIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.8 | Oversold |
| Stochastic | 3.3 | Oversold |
HLIO's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over HLIO on valuation relative to its sector.
HLIO PE vs Industrials Sector
| Metric | HLIO | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 24x | 16% below |
| PE % | 12 | 58 | 46 pts below |
HLIO is trading at 20x earnings, a 16% discount to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
HLIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.1 | 24% below |
| 20 week MA | $71.6 | 33% below |
| 50 week MA | $70.2 | 32% below |
| 100 week MA | $56.0 | 15% below |
| 200 week MA | $53.9 | 11% below |
HLIO is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
HLIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.5 | $52.8 | +16% |
| 2021 | $52.8 | $103.1 | +95% |
| 2022 | $103.1 | $54.8 | -47% |
| 2023 | $54.8 | $45.4 | -17% |
| 2024 | $45.4 | $45.0 | -0.8% |
| 2025 | $45.0 | $55.5 | +23% |
| 2026 YTD | $55.5 | $47.7 | -14% |
HLIO has the edge over BA on returns for 2026, with the stronger performance.